HK1225616B - 用於治療血液腫瘤的羥烷基澱粉 - Google Patents

用於治療血液腫瘤的羥烷基澱粉

Info

Publication number
HK1225616B
HK1225616B HK16113883A HK16113883A HK1225616B HK 1225616 B HK1225616 B HK 1225616B HK 16113883 A HK16113883 A HK 16113883A HK 16113883 A HK16113883 A HK 16113883A HK 1225616 B HK1225616 B HK 1225616B
Authority
HK
Hong Kong
Prior art keywords
treatment
hydroxyalkyl starch
hematological neoplasms
neoplasms
hematological
Prior art date
Application number
HK16113883A
Other languages
English (en)
Inventor
Martin Westphal
Silke Baasner
Original Assignee
Fresenius Kabi Deutschland Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fresenius Kabi Deutschland Gmbh filed Critical Fresenius Kabi Deutschland Gmbh
Publication of HK1225616B publication Critical patent/HK1225616B/zh

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716Glucans
    • A61K31/718Starch or degraded starch, e.g. amylose, amylopectin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/21Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/255Esters, e.g. nitroglycerine, selenocyanates of sulfoxy acids or sulfur analogues thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • A61P35/02Antineoplastic agents specific for leukemia

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Emergency Medicine (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
HK16113883A 2013-07-30 2016-12-06 用於治療血液腫瘤的羥烷基澱粉 HK1225616B (zh)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP13003776 2013-07-30

Publications (1)

Publication Number Publication Date
HK1225616B true HK1225616B (zh) 2017-09-15

Family

ID=48906086

Family Applications (1)

Application Number Title Priority Date Filing Date
HK16113883A HK1225616B (zh) 2013-07-30 2016-12-06 用於治療血液腫瘤的羥烷基澱粉

Country Status (11)

Country Link
US (1) US10272102B2 (zh)
EP (1) EP3027211B1 (zh)
KR (1) KR20160045072A (zh)
CN (1) CN106232142B (zh)
AU (1) AU2014298486B2 (zh)
CA (1) CA2919322C (zh)
ES (1) ES2658400T3 (zh)
HK (1) HK1225616B (zh)
NZ (1) NZ716610A (zh)
PL (1) PL3027211T3 (zh)
WO (1) WO2015014851A1 (zh)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI770624B (zh) 2018-06-15 2022-07-11 漢達生技醫藥股份有限公司 尼洛替尼十二烷基硫酸鹽在製備用於治療慢性骨髓性白血病之劑型的用途

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4023789A1 (de) 1990-07-26 1992-01-30 Schumann Klaus Verwendung einer waessrigen loesung einer poly-(o-hydroxyalkyl)-staerke
DE4023788A1 (de) * 1990-07-26 1992-01-30 Schumann Klaus Verwendung einer waessrigen loesung einer poly-(o-hydroxyalkyl)-staerke
US6207654B1 (en) 1996-05-03 2001-03-27 Bashir Zikria Capillary membrane stabilization and reduction of inflammation during the course of chemotherapy or antiviral treatment through the use of biodegradable macromolecules and interleukin-2
KR20190132556A (ko) * 2007-09-28 2019-11-27 안트로제네시스 코포레이션 인간 태반 관류액 및 인간 태반-유래 중간체 천연 킬러 세포를 사용한 종양 억제 방법
KR20170060179A (ko) * 2008-11-13 2017-05-31 길리아드 칼리스토가 엘엘씨 혈액 종양에 대한 요법
EP2398482B1 (en) 2009-02-17 2017-04-19 NovelMed Therapeutics, Inc. Methods and compositions for inhibiting cellular proliferation and surgical adhesion
JP2013509444A (ja) * 2009-10-30 2013-03-14 アリアド・ファーマシューティカルズ・インコーポレイテッド がんの治療方法及び治療用組成物
WO2013113747A1 (en) 2012-01-30 2013-08-08 Fresenius Kabi Deutschland Gmbh Hydroxyalkyl starch for the treatment of cancers by reduction of tumor growth rates

Also Published As

Publication number Publication date
PL3027211T3 (pl) 2018-04-30
EP3027211A1 (en) 2016-06-08
CA2919322A1 (en) 2015-02-05
AU2014298486A1 (en) 2016-02-25
ES2658400T3 (es) 2018-03-09
CA2919322C (en) 2016-07-05
US20160175341A1 (en) 2016-06-23
AU2014298486B2 (en) 2019-01-24
US10272102B2 (en) 2019-04-30
WO2015014851A1 (en) 2015-02-05
KR20160045072A (ko) 2016-04-26
CN106232142A (zh) 2016-12-14
NZ716610A (en) 2019-10-25
EP3027211B1 (en) 2017-11-01
CN106232142B (zh) 2020-04-03

Similar Documents

Publication Publication Date Title
GB201421334D0 (en) Synthesis of aeizeolite
EP2954880A4 (en) CULOTTE TYPE LAYER
EP2997956A4 (en) WATER IN OIL COSMETIC
GB2512653B (en) Interference mitigation
HRP20181710T1 (hr) Uporaba derivata benzimidazol-prolina
SI2971384T1 (sl) Sanitarni vložek
SG11201509249YA (en) Highly porous aerogels
EP3015100A4 (en) COSMETIC PRODUCT
ZA201405781B (en) Non-wax paper coating
EP2954881A4 (en) UNDERWEAR WINDEL
HK1225616B (zh) 用於治療血液腫瘤的羥烷基澱粉
HRP20190360T1 (hr) Obložno sredstvo koje sadrži hidroksialkilcelulozu
GB201321226D0 (en) Interference mitigation
PL2787133T3 (pl) Urządzenie sanitarne
PL3016948T3 (pl) 2-acyloaminotiazole do leczenia nowotworów
HRP20182087T1 (hr) Ležišta za sušenje mulja
HK1213938A1 (zh) 衛生施用器
IL244411A0 (en) A procedure for the synthesis of derivatives of n-benzyl-n-cyclopropyl-1h-pyrazole-4-carboxamide
GB2529970B (en) Shower
GB201322922D0 (en) Synthesis of Polyoxometalates
AU5186P (en) VOC1 Viburnum odoratissimum
GB201321636D0 (en) Diaper
AU351250S (en) Paper tissue
GB201311534D0 (en) Concept fifteen
GB201307201D0 (en) New compounds and uses

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20230726